OK
Plastics & Elastomers
Industry News

UR Utilizes BASF’s Rigid Foam to Produce Insulated Panels for Vaccine Storage Facilities

Published on 2021-06-07. Edited By : SpecialChem

TAGS:  Medical     High Heat Materials   

insulation-panel-vaccine-facilities BASF’s Elastopir® PH 1132/509/0, a high-quality polyurethane rigid foam insulation solution is used by United Panel-System (UR) in the manufacture of insulated panels for COVID-19 vaccine logistics storage facilities.

Reliable Cold Storage


As vaccines need to be preserved in super cold temperatures ranging from minus 70°C to plus 8°C to maintain their potency, the reliability of cold storages is extra important. BASF’s Elastopir® solutions provides extra-high temperature stability for the interiors, coupled with United Panel’s sound technological expertise for commercial refrigeration systems, UR is able to produce high-quality COVID-19 vaccine storage facilities for customers across Asia.

Sustainability is also an important benefit of BASF’s Elastopir® solutions. Elastopir® PH 1132/509/0 is a n-pentane-blown foam, with a low global warming and ozone depletion potential. Additionally, the solution aids lower energy consumption, increasing the facilities’ energy efficiency, an important consideration in many parts of Asia where electricity supply is hard to come by.

Superior Fire Performance


Elastopir® has superior fire performance, which enhances the protection of these facilities against fires. It was also recently used to produce mobile medical Intensive Care Unit (ICU) facilities by Rinac India Limited to support India’s urgent need for more hospital beds during the pandemic.

It is heartening to know that BASF’s Elastopir® solution is playing a part to support the COVID-19 vaccination programs in different locations,” said Andy Postlethwaite, senior vice president, Performance Materials Asia Pacific, BASF. “Our collaboration with United Panel once again demonstrates our spirit to “go beyond,” as we work together to produce the highest quality panels for the vaccine storage facilities.”


Source: BASF
Back to Top